Nifty Bank & Auto Stocks Drag Market Lower; Pharma Stocks Rally: Key Levels to Watch

Image Source: BSEINDIACC BY-SA 3.0, via Wikimedia Commons

It was a bruising day for the Indian stock market today as a wave of selling pressure swept across most sectors, leaving investors with little room to hide.

The overall mood turned decidedly cautious as benchmark indices surrendered significant ground, reflecting a sombre sentiment on Dalal Street.

The Bse Sensex took a sharp hit, tumbling 852.49 points to close at 77,664.00, while the Nifty 50 slipped below the 24,200 mark, ending the session at 24,173.05.

The Nifty Bank also faced heavy weather, shedding over 800 points as major private and public sector lenders saw their stock prices erode.

The story of the day was the stark contrast in sector performance. The Nifty Auto index was among the biggest draggers, sliding 2.35% as heavyweights like Mahindra & Mahindra fell 3.30%.

The banking and financial services space also struggled; the Nifty Psu Bank index dropped 2.19%, while the Nifty Private Bank index saw a decline of 1.31%.

Even the high-flying IT sector couldn’t escape the carnage, with the Nifty IT index falling 1.22% as Tech Mahindra and Infosys joined the list of notable laggards.

However, it wasn’t all gloom. The Nifty Pharma sector stood out as a beacon of resilience, surging 2.36% as investors sought safety in defensive plays. The Nifty Mid-Small Healthcare index also posted a gain of 1.08%, further highlighting the strength in the broader healthcare space.

Looking at individual stocks, Trent emerged as one of the most prominent top losers, sliding 4.21%. The pain was widespread among blue chips, with Bajaj Finserv, Tech Mahindra, and Mahindra & Mahindra all seeing significant cuts. Banking giants like Hdfc Bank and Kotak Bank also ended the day in the red, down 1.93% and 1.83% respectively.

On the flip side, a few stocks managed to swim against the tide. Adani Ports led the top gainers with a nearly 1% rise, closely followed by engineering major Larsen & Toubro. Sun Pharma also capitalised on the sector-wide tailwinds to end 0.64% higher.

DisclaimerThe information provided is for educational purposes only and does not constitute financial advice. We are not registered financial advisors. Please conduct your own research and consult a qualified advisor before making investment decisions. Any investment decisions you make based on this information are solely at your own risk.